Showing results (1-10 of 154) with videos related to
Sort By:
Pageof 16
Minerva Medica|April 30, 1976
[The vanishing testis syndrome. Considerations on a case]G Vailati, M Montini, A Ongaro, et al.Minerva Medica|April 30, 1976
[Synthetic PH-RH as a pituitary function test in anorexia nervosa]G Vailati, M Montini, A Ongaro, et al.Arzneimittel-Forschung|August 1, 1975
[Controlled application of cynarin in the treatment of hyperlipemic syndrome. Observations in 60 cases]M Montini, P Levoni, A Ongaro, et al.European Journal of Endocrinology|January 1, 1997
Growth hormone binding protein and growth hormone availability in acromegalic patients treated with long-acting octreotide (Sandostatin-LAR)S Fisker, A Kaal, M Montini, et al.The Journal of Clinical Endocrinology and Metabolism|July 1, 1986
Long-lasting suppression of prolactin secretion and rapid shrinkage of prolactinomas after a long-acting, injectable form of bromocriptineM Montini, G Pagani, D Gianola, et al.Clinical Endocrinology|March 1, 1994
Cholelithiasis and acromegaly: therapeutic strategiesM Montini, D Gianola, M D Pagani, et al.International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1991
Hypocalcemic effects of rectal and intramuscular administration of synthetic salmon calcitoninG Pagani, M D Pagani, D Gianola, et al.Journal of Endocrinological Investigation|March 10, 2005
Treatment of acromegaly with SS analogues: should GH and IGF-I target levels be lowered to assert a tight control of the disease?R Cozzi, R Attanasio, S Grottoli, et al.Clinical Endocrinology|April 1, 1992
Efficacy of a new long-acting injectable form of bromocriptine in hyperprolactinaemic patientsM D Pagani, F Tengattini, M Montini, et al.Endocrinologia Experimentalis|March 1, 1990
New perspectives in medical management of hyperprolactinemiaM Montini, D Gianola, M D Pagani, et al.Pageof 16